PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-09-17

Date Title Company
17-Sep-2025 Deciphera Receives European Commission Approval of ROMVIMZA™ (vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor (TGCT) Businesswire
17-Sep-2025 Families of Victims in Air India 171 Crash Sue Boeing, Honeywell Businesswire
17-Sep-2025 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
17-Sep-2025 Enveric Biosciences Announces Exercise of Warrants for $2.2 Million Gross Proceeds Businesswire
17-Sep-2025 SiTime Enters $4B Resonator Market with Titan Platform™ Businesswire
17-Sep-2025 Lumata Health Expands Leadership Bench with New Chief Technology Officer and Chief Growth Officer Businesswire
17-Sep-2025 Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Biosciences, Slingshot Biosciences and AltemisLab, to Expand Cell Q’s Capabilities in Meeting Demands for Commercial Scale Cell Therapy Quality Control Businesswire
17-Sep-2025 Colossal Advances Dodo De-Extinction with Significant, World’s First Breakthrough in Pigeon PGCs and Secures an Additional $120M in Funding for Species Expansion Businesswire
17-Sep-2025 Medicine shortages still a chronic headache for the EU European Court of Auditors
17-Sep-2025 Crown Bioscience Expands US Presence with New Model Development Center in Kannapolis, North Carolina Businesswire
17-Sep-2025 bioAffinity Technologies Announces 1-for-30 Reverse Stock Split Effective at the Open of Trading on September 19, 2025 Businesswire
17-Sep-2025 NewMarket Corporation Announces the Acquisition of Calca Solutions, LLC Businesswire
17-Sep-2025 TEAM Technologies, an Arlington Capital Partners Portfolio Company, Acquires TAG3 Engineering to Expand Medical Device Design and Development Capabilities Businesswire
17-Sep-2025 Medincell Partner Teva to Host Investor Call on Completed Phase 3 Olanzapine LAI Data Following Psych Congress 2025 Presentation Businesswire
17-Sep-2025 Astria Therapeutics Announces Positive Initial Results from the Phase 1a Healthy Subject Trial of STAR-0310 at the European Academy of Dermatology and Venereology Businesswire
17-Sep-2025 Luxa Biotechnology Announces Publication in Cell Stem Cell Describing Positive Clinical Results for First-in-Human Clinical Trial for Dry AMD Therapy Businesswire
17-Sep-2025 Rubedo Life Sciences Announces U.S. FDA Clearance of IND for Selective GPX4 Modulating Lead Drug Candidate RLS-1496 for Actinic Keratosis, Expands Clinical Advisory Board Businesswire
17-Sep-2025 TEAM Technologies Acquires TAG3 Engineering, Adding Front End Design and Product Innovation to its Suite of Capabilities to Service the Medical Device Industry Businesswire
17-Sep-2025 Enveric Biosciences Announces Publication of Two Peer-Reviewed Articles Highlighting Novel Bioproduction Methods for Neuropsychiatric Drug Discovery Businesswire
17-Sep-2025 EASD 2025 | HighTide Therapeutics Announces Oral Presentation of Phase 3 Data in Patients with Type 2 Diabetes HighTide Therapeutics Inc.